Alison Boyle
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
-
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Hepatitis C virus research 4
-
- Pharmacogenetics and Drug Metabolism 4
- Drug-Induced Hepatotoxicity and Protection 2
- Co-authors
- Catia Marzolini (6 shared papers)Saye Khoo (6 shared papers)Fiona Marra (10 shared papers)David J. Back (5 shared papers)Sara Gibbons (4 shared papers)David Marinus Burger (3 shared papers)Laura Jane Waters (1 shared paper)Daniel R. Kuritzkes (1 shared paper)
- Journals
- Journal of Hepatology (3 papers)Journal of Viral Hepatitis (2 papers)British Journal of Clinical Pharmacology (1 paper)Journal of Critical Care (1 paper)Clinical Pharmacokinetics (1 paper)
- Partner nations
- United KingdomSwitzerlandNetherlands
In The Last Decade
Alison Boyle
13 papers receiving 339 citations
Alison Boyle's Hit Papers
Peers
Comparison fields: 5 of 69
- Infectious Diseases 156
- Pharmacology 33
- Transplantation 8
- Biological Psychiatry 6
- Geriatrics and Gerontology 8
Countries citing papers authored by Alison Boyle
This map shows the geographic impact of Alison Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Boyle more than expected).
Fields of papers citing papers by Alison Boyle
This network shows the impact of papers produced by Alison Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Boyle. The network helps show where Alison Boyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Boyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Recommendations for the Management of Drug–Drug Interactions Between the COVID ‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications Hit paper breakdown → | 2022 | 190 |
| 2 | 2020 | 42 | |
| 3 | 2019 | 31 | |
| 4 | 2020 | 28 | |
| 5 | 2020 | 23 | |
| 6 | 2022 | 9 | |
| 7 | 2019 | 7 | |
| 8 | 2024 | 5 | |
| 9 | 2022 | 4 | |
| 10 | 2019 | 3 | |
| 11 | 2011 | 2 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 1 |
About Alison Boyle
Alison Boyle is a scholar working on Hepatology, Pharmacology, Infectious Diseases, Emergency Medicine and Psychiatry and Mental health, having authored 13 papers that have together received 346 indexed citations. Recurring topics across this work include Hepatitis C virus research (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), HIV/AIDS drug development and treatment (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Schizophrenia research and treatment (2 papers), Heparin-Induced Thrombocytopenia and Thrombosis (2 papers), Tryptophan and brain disorders (1 paper) and COVID-19 Clinical Research Studies (1 paper). The work is most often cited by research in Infectious Diseases (156 citations), Pharmacology (33 citations), Transplantation (8 citations), Biological Psychiatry (6 citations) and Geriatrics and Gerontology (8 citations). Alison Boyle has collaborated with scholars based in United Kingdom, Switzerland and Netherlands. Frequent co-authors include Catia Marzolini, Saye Khoo, Fiona Marra, David J. Back, Sara Gibbons, David Marinus Burger, Laura Jane Waters, Daniel R. Kuritzkes, Marta Boffito and Anton Louis Pozniak. Their work appears in journals such as Journal of Hepatology, Journal of Viral Hepatitis, British Journal of Clinical Pharmacology, Journal of Critical Care and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.